Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review


Autoři: Amanda P. Miller aff001;  Mohsen Malekinejad aff001;  Hacsi Horváth aff001;  Janet C. Blodgett aff001;  James G. Kahn aff001;  Suzanne M. Marks aff004
Působiště autorů: Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, United States of America aff001;  Division of Infectious Disease and Global Public Health, School of Medicine, University of California, San Diego, La Jolla, California, United States of America aff002;  Global Health Sciences, University of California, San Francisco, San Francisco, California, United States of America aff003;  Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America aff004
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: 10.1371/journal.pone.0223077

Souhrn

Context

An estimated 21% of non-U.S.-born persons in the United States have a reactive tuberculin skin test (TST) and are at risk of progressing to TB disease. The effectiveness of strategies by healthcare facilities to improve targeted TB infection testing and linkage to care among this population is unclear.

Evidence acquisition

Following Cochrane guidelines, we searched several sources to identify studies that assessed strategies directed at healthcare providers and/or non-U.S.–born patients in U.S. healthcare facilities.

Evidence synthesis

Seven studies were eligible. In a randomized controlled trial (RCT), patients with reactive TST who received reminders for follow-up appointments were more likely to attend appointments (risk ratio, RR = 1.05, 95% confidence interval 1.00–1.10), but rates of return in a quasi-RCT study using patient reminders did not significantly differ between study arms (P = 0.520). Patient-provider language concordance in a retrospective cohort study did not increase provider referrals for testing (P = 0.121) or patient testing uptake (P = 0.159). Of three studies evaluating pre and post multifaceted interventions, two increased TB infection testing (from 0% to 77%, p < .001 and RR 2.28, 1.08–4.80) and one increased provider referrals for TST (RR 24.6, 3.5–174). In another pre-post study, electronic reminders to providers increased reading of TSTs (RR 2.84, 1.53–5.25), but only to 25%. All seven studies were at high risk of bias.

Conclusions

Multifaceted strategies targeting providers may improve targeted TB infection testing in non-U.S.-born populations visiting U.S. healthcare facilities; uncertainties exist due to low-quality evidence. Additional high-quality studies on this topic are needed.

Klíčová slova:

Allied health care professionals – Database searching – Health care facilities – Health care providers – Language – Screening guidelines – Systematic reviews – Tuberculosis


Zdroje

1. Global Tuberculosis Report. Geneva: World Health Organization, 2018.

2. Centers for Disease Control and Prevention (CDC). Reported Tuberculosis in the United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC., 2018.

3. Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR Jr., Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014;179(2):216–25. Epub 2013/10/22. doi: 10.1093/aje/kwt246 24142915; PubMed Central PMCID: PMC5547435.

4. Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, et al. Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011–2012. PLoS One. 2015;10(11):e0140881. Epub 2015/11/05. doi: 10.1371/journal.pone.0140881 26536035; PubMed Central PMCID: PMC4633161.

5. Yuen CM, Kammerer JS, Marks K, Navin TR, France AM. Recent Transmission of Tuberculosis—United States, 2011–2014. PLoS One. 2016;11(4):e0153728. Epub 2016/04/16. doi: 10.1371/journal.pone.0153728 27082644; PubMed Central PMCID: PMC4833321.

6. CDC. Tuberculosis Technical Instructions for Panel Physicians. [2/20/2019]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.html.

7. CDC. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recommendations and Reports. 1995;44(RR-11):19–34. 7565540

8. CDC. Targeted Tuberculin Testing for Latent Tuberculosis Infection MMWR. 2000;49(RR06):1–54.

9. U. S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, et al. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(9):962–9. Epub 2016/09/07. doi: 10.1001/jama.2016.11046 27599331.

10. Flood J, Barry PM. Mainstreaming Latent Tuberculosis Infection Testing and Treatment in the United States: Who and How. JAMA Intern Med. 2017. Epub 2017/10/20. doi: 10.1001/jamainternmed.2017.4916 29049821.

11. Lebrun LA, Dubay LC. Access to primary and preventive care among foreign-born adults in Canada and the United States. Health Serv Res. 2010;45(6 Pt 1):1693–719. Epub 2010/09/08. doi: 10.1111/j.1475-6773.2010.01163.x 20819107; PubMed Central PMCID: PMC3026954.

12. Vozoris NT, Batt J. Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999–2012. Can Respir J. 2016;2016:1850879. Epub 2016/07/23. doi: 10.1155/2016/1850879 27445519; PubMed Central PMCID: PMC4904560.

13. Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017;12(8):e0180707. Epub 2017/08/09. doi: 10.1371/journal.pone.0180707 28786991; PubMed Central PMCID: PMC5546677.

14. Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration; 2011. Available from: http://www.cochrane-handbook.org.

15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. Epub 2009/07/22. doi: 10.1371/journal.pmed.1000097 19621072; PubMed Central PMCID: PMC2707599.

16. CDC. Guidelines for Screening for Tuberculosis Infection and Disease During the Domestic Medical Examination for Newly Arrived Refugees Atlanta, Georgia: CDC; 2014 [updated February 6, 2014; cited December 16, 2016]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domestic-guidelines.html.

17. Center for Disease Control and Prevention. TB Notes Newsletter. 2000–2018.

18. Davidow AL, Katz D, Ghosh S, Blumberg H, Tamhane A, Sevilla A, et al. Preventing Infectious Pulmonary Tuberculosis Among Foreign-Born Residents of the United States. American Journal of Public Health. 2015;105(9):E81–E8. WOS:000364322600019. doi: 10.2105/AJPH.2015.302662 26180947

19. Reuters. T. Endnote X7. ENDNOTE. New York, New York, USA: Thomas Reuters; 2013.

20. Stata. College Station, Texas: StatCorp LP; 2015.

21. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380–2. Epub 2010/12/28. doi: 10.1016/j.jclinepi.2010.09.011 21185693.

22. Kempker JA, Pasquel FJ, Castejon MS, Acosta A, Zaragoza-Macias E, Ilksoy N, et al. Quality improvement of tuberculosis screening in foreign-born patients. Journal of immigrant and minority health / Center for Minority Public Health. 2012;14(1):1–5. Epub 2011/05/19. doi: 10.1007/s10903-011-9479-0 21590335.

23. Leng JC, Changrani J, Gany FM. Language discordance and testing for latent tuberculosis infection among recent Asian and Latino immigrants. J Community Health. 2011;36(2):228–30. Epub 2010/08/11. doi: 10.1007/s10900-010-9301-2 20697787.

24. Steele AW, Eisert S, Davidson A, Sandison T, Lyons P, Garrett N, et al. Using computerized clinical decision support for latent tuberculosis infection screening. American journal of preventive medicine. 2005;28(3):281–4. Epub 2005/03/16. doi: 10.1016/j.amepre.2004.12.012 15766616.

25. Schultz JS, Floyd E, Guitierrez C, Manning W, Newton TP, Frank A, et al. Scientific Abstracts. Journal of General Internal Medicine. 2018;33(S2):83–840. doi: 10.1007/s11606-018-4413-y

26. Anand A, Wagner C, Kong SS, Griffith E, Harimtepathip P, Baker KK, et al. Improving Screening for Latent Tuberculosis Infection in a Student-run Free Clinic. Cureus. 2018;10(4):e2488. Epub 2018/06/21. doi: 10.7759/cureus.2488 29922529; PubMed Central PMCID: PMC6003801.

27. Tanke ED, Martinez CM, Leirer VO. Use of automated reminders for tuberculin skin test return. American journal of preventive medicine [Internet]. 1997; 13(3):[189–92 pp.]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/476/CN-00140476/frame.html. 9181206

28. Tanke ED, Leirer VO. Automated Telephone Reminders in Tuberculosis Care Medical Care. 1994;32(4):380–9. doi: 10.1097/00005650-199404000-00006 WOS:A1994NE24600006. 8139302

29. CDC. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. MMWR Recommendations and Reports. 2000;49(RR06):1–54.

30. Volmink J, Garner P. Interventions for promoting adherence to tuberculosis management. The Cochrane database of systematic reviews. 2000;4.

31. Leng JC, Changrani J, Gany FM. Language discordance and testing for latent tuberculosis infection among recent Asian and Latino immigrants. Journal of community health [Internet]. 2011; 36(2):[228–30 pp.]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/875/CN-00787875/frame.html. doi: 10.1007/s10900-010-9301-2 20697787

32. Hsu L, Bowlus CL, Stewart SL, Nguyen TT, Dang J, Chan B, et al. Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci. 2013;58(3):807–14. Epub 2012/10/18. doi: 10.1007/s10620-012-2396-9 23073671; PubMed Central PMCID: PMC3578075.

33. Drainoni ML, Litwin AH, Smith BD, Koppelman EA, McKee MD, Christiansen CL, et al. Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting. Am J Public Health. 2012;102(11):e115–21. Epub 2012/09/22. doi: 10.2105/AJPH.2012.300659 22994166; PubMed Central PMCID: PMC3477946.

34. Litwin AH, Smith BD, Drainoni ML, McKee D, Gifford AL, Koppelman E, et al. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2012;44(6):497–503. Epub 2012/02/22. doi: 10.1016/j.dld.2011.12.014 22342471.

35. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;(2):CD003030. Epub 2009/04/17. doi: 10.1002/14651858.CD003030.pub2 19370580.

36. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009;(3):CD001096. Epub 2009/07/10. doi: 10.1002/14651858.CD001096.pub2 19588323; PubMed Central PMCID: PMC4171964.

37. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. The Cochrane database of systematic reviews. 2012;(6):CD000259. doi: 10.1002/14651858.CD000259.pub3 22696318.


Článek vyšel v časopise

PLOS One


2019 Číslo 9

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Léčba bolesti v ordinaci praktického lékaře
nový kurz
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se